Discover

CTSO
Cytosorbents Corporation
0.36
110 x 0.37
2 x 0.38
bid
ask
-
0.00
0.55%
17 @ 04:00 PM
0.38 +0.02 (6.64%)
Ytd-43.66%
1y-70.00%
0.36
day range
0.38
0.35
52 week range
1.19
Open0.37Prev Close0.36Low0.36High0.38Mkt Cap22.62M
Vol36.51KAvg Vol159.60KEPS-0.26P/E-1.38Forward P/E-5.99
Beta0.56Short Ratio9.57Inst. Own33.29%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg0.40200-d Avg0.601yr Est5.00
Income Statement
Total Revenue9.63M
Revenues (USD)9.63M
Cost of Revenue2.58M
Gross Profit7.05M
Operating Expenses9.69M
Research and Development Expense1.45M
Selling, General and Administrative Expense7.96M
Operating Income-2.64M
Interest Expense868.00K
Net Income-4.42M
Net Income Common Stock-4.42M
Net Income Common Stock (USD)-4.42M
Consolidated Income-4.42M
Earnings per Basic Share-0.07
Earnings per Basic Share (USD)-0.07
Earnings per Diluted Share-0.07
Earning Before Interest & Taxes (EBIT)-3.55M
Earning Before Interest & Taxes (USD)-3.55M
Weighted Average Shares62.81M
Weighted Average Shares Diluted62.81M
Balance Sheet
Cash and Equivalents5.94M
Cash and Equivalents (USD)5.94M
Trade and Non-Trade Receivables6.79M
Current Assets15.74M
Property, Plant & Equipment Net17.78M
Total Assets37.96M
Debt Current14.15M
Total Debt28.84M
Current Liabilities24.02M
Debt Non-Current14.69M
Total Liabilities38.71M
Accumulated Retained Earnings (Deficit)-321.75M
Accumulated Other Comprehensive Income-996.00K
Shareholders Equity-751.00K
Shareholders Equity (USD)-751.00K
Assets Non-Current22.22M
Total Debt (USD)28.84M
Goodwill and Intangible Assets2.86M
Inventory3.69M
Liabilities Non-Current14.69M
Trade and Non-Trade Payables2.00M
Cash Flow
Depreciation, Amortization & Accretion314.00K
Net Cash Flow / Change in Cash & Cash Equivalents-400.00K
Capital Expenditure45.00K
Net Cash Flow from Investing7.00K
Net Cash Flow from Operations-583.00K
Effect of Exchange Rate Changes on Cash 176.00K
Share Based Compensation368.00K